iShares Biotechnology ETF
IBB
IBB
670 hedge funds and large institutions have $5.57B invested in iShares Biotechnology ETF in 2019 Q1 according to their latest regulatory filings, with 98 funds opening new positions, 192 increasing their positions, 234 reducing their positions, and 67 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding
Funds holding: →
17% less funds holding in top 10
Funds holding in top 10: 18 → 15 (-3)
18% less repeat investments, than reductions
Existing positions increased: 192 | Existing positions reduced: 234
32% less call options, than puts
Call options by funds: $392M | Put options by funds: $579M
Holders
670
Holding in Top 10
15
Calls
$392M
Puts
$579M
Top Buyers
| 1 | +$190M | |
| 2 | +$152M | |
| 3 | +$95.6M | |
| 4 |
Citigroup
New York
|
+$82.7M |
| 5 |
DFO
Duquesne Family Office
New York
|
+$49.3M |
Top Sellers
| 1 | -$68.6M | |
| 2 | -$52.7M | |
| 3 | -$47.3M | |
| 4 |
State of Tennessee, Department of Treasury
Nashville,
Tennessee
|
-$40.7M |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$33.7M |